PharmaCyte Biotech, Inc.

10-K Fiscal year ended 2026-04-30 Jul 29, 2026 8-K Director or officer change; Shareholder vote results Apr 2, 2026 10-Q Quarter ended 2026-01-31 Mar 17, 2026 10-Q Quarter ended 2025-10-31 Dec 18, 2025 8-K Delisting notice or listing-rule failure Dec 5, 2025 8-K/A Nov 18, 2025 8-K Director or officer change; Shareholder vote results Oct 31, 2025 10-Q Quarter ended 2025-07-31 Sep 15, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Sep 5, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Aug 18, 2025 10-K Fiscal year ended 2025-04-30 Aug 11, 2025 8-K Shareholder vote results Apr 24, 2025 10-Q Quarter ended 2025-01-31 Mar 17, 2025 8-K Changed accountants Feb 26, 2025 10-Q Quarter ended 2024-10-31 Dec 13, 2024 10-Q Quarter ended 2024-07-31 Sep 17, 2024 10-K Fiscal year ended 2024-04-30 Aug 13, 2024 8-K Entered a material agreement; Completed an acquisition or disposition; Other events May 23, 2024 8-K Shareholder vote results May 1, 2024 10-Q Quarter ended 2024-01-31 Mar 18, 2024 10-Q Quarter ended 2023-10-31 Dec 15, 2023 8-K Director or officer change Nov 24, 2023 8-K Entered a material agreement; Other events Nov 16, 2023 8-K Changed accountants Nov 9, 2023 10-Q Quarter ended 2023-07-31 Sep 18, 2023 8-K Amended charter or bylaws; Shareholder vote results Sep 7, 2023 8-K Changed accountants Aug 4, 2023 10-K Fiscal year ended 2023-04-30 Jul 31, 2023 8-K Amended charter or bylaws; Other events Jul 19, 2023 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Shareholder vote results; Other events May 11, 2023 10-Q Quarter ended 2023-01-31 Mar 16, 2023 8-K Other events Feb 2, 2023 8-K Shareholder vote results Dec 30, 2022 10-Q Quarter ended 2022-10-31 Dec 14, 2022 8-K Director or officer change; Amended charter or bylaws Nov 18, 2022 8-K Director or officer change Nov 7, 2022 8-K Director or officer change; Item 5.08; Other events Oct 14, 2022 8-K Director or officer change; Regulation FD disclosure Oct 7, 2022 10-Q Quarter ended 2022-07-31 Sep 14, 2022 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Aug 16, 2022